Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
Public ClinicalTrials.gov record NCT01643590. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a randomized, double-blind, placebo controlled Phase II study is designed to assess the safety and efficacy of using JVS-100 to treat heart failure.
Study identification
- NCT ID
- NCT01643590
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 90 participants
Conditions and interventions
Conditions
Interventions
- JVS-100 15 mg dose Injection Biological
- Placebo Injection Biological
- JVS-100 30 mg dose injection Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2012 (Type not available)
- Primary completion
- Oct 2014 (Estimated)
- Completion
- Nov 2014 (Estimated)
- Last update posted
- Feb 7, 2014
2012 – 2014
United States locations
- U.S. sites
- 16
- U.S. states
- 12
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cardiology PC | Birmingham | Alabama | 35211 | — |
| University of Florida | Gainesville | Florida | 32603 | — |
| Pepin Heart Institute | Tampa | Florida | 33613 | — |
| Iowa Heart Center | Des Moines | Iowa | 50026 | — |
| Johns Hopkins University | Baltimore | Maryland | 21287 | — |
| Spectrum Health | Grand Rapids | Michigan | 49503 | — |
| Michigan Cardiovascular Institute | Saginaw | Michigan | 48601 | — |
| Minneapolis Heart Institute | Minneapolis | Minnesota | 55407 | — |
| Washington University in St. Louis | St Louis | Missouri | 63110 | — |
| Columbia University Medical Center | New York | New York | 10032 | — |
| Montefiore Medical Center | New York | New York | 10476 | — |
| Summa Health System | Akron | Ohio | 44309 | — |
| The Lindner Center at the Christ Hospital | Cincinnati | Ohio | 45238 | — |
| University of Pennsylvania Health System | Philadelphia | Pennsylvania | 19104 | — |
| Baylor Healthcare | Dallas | Texas | 75226 | — |
| University of Utah | Salt Lake City | Utah | 84132 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01643590, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 7, 2014 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01643590 live on ClinicalTrials.gov.